Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

IcelandBack to Iceland

Clinical trials in Reykjavik – page 2

27 clinical trials in Reykjavik, Iceland. Every trial is listed in the EU Clinical Trials Register and updated daily.

IcelandOur site in IcelandKliniskarRannsoknir.is(opens in a new tab)
Reykjavik at a glance
27
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

27 trials in Reykjavik

Open in trial search

Cerebral amyloid angiopathy

Not yet recruiting

Study on the Safety and Effects of Acetylcysteine Amide for Patients Aged 12 and Over with Hereditary Cystatin C Amyloid Angiopathy

InvestigationalNo placebo
Countries:IcelandIceland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Acetylcysteine Amide
  • Sponsor:Arctic Therapeutics ehf.

Arteriosclerosis

Not recruiting

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting

Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

InvestigationalNo placebo
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Study on the Safety and Effects of NPI-001 (Acetylcysteine Amide) for Patients Aged 50-85 with Mild Cognitive Impairment or Mild Alzheimer's Disease

Not recruiting
Investigational
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylcysteine Amide
  • Sponsor:Arctic Therapeutics ehf.

Primary biliary cholangitis

Not recruiting

Study on the Safety and Effectiveness of Saroglitazar Magnesium for Patients with Primary Biliary Cholangitis

Investigational
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Saroglitazar hemimagnesium
  • Sponsor:Zydus Therapeutics Inc.

Non-small cell lung cancer

Not recruiting

Study on JDQ443 and Docetaxel for Patients with Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Novartis Pharma AG

Cerebral amyloid angiopathy

Not recruiting

Study on the Safety and Effects of Acetylcysteine Amide for Patients Aged 12 and Over with Hereditary Cystatin C Amyloid Angiopathy

InvestigationalNo placebo
Countries:IcelandIceland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Acetylcysteine Amide
  • Sponsor:Arctic Therapeutics ehf.

Hypertrophic cardiomyopathy

Not recruiting

Study on Aficamten for Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Investigational
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Aficamten
  • Sponsor:Cytokinetics Inc.

Breast cancer

Not recruiting

Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy

Registered drug
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:AstraZeneca AB

Infertility

Not recruiting

Study on Vaginal Progesterone for Improving Live Birth Rates in Women with Infertility Undergoing Frozen/Thawed IVF Natural Cycles

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:18–64 years
  • Substances:Progesterone
  • Sponsor:Vaestra Goetalandsregionen

Small cell lung cancer extensive stage

Not recruiting

Study on the Effect of Adding Thoracic Radiotherapy to Durvalumab and Chemotherapy for Patients with Extensive Stage Small-Cell Lung Cancer

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology

Other cities in Iceland

The busiest research cities in the country

All 2 cities in Iceland

Clinical research in Reykjavik

What the registry says about research in the country

01 Cardiovascular Research

Innovative trials exploring treatments for cardiovascular diseases, including studies on lipoprotein reduction and atherosclerosis prevention. Research focuses on reducing major cardiovascular events in high-risk patients.

  • Atherosclerotic Disease Management
  • Hypertrophic Cardiomyopathy
  • Post-Bypass Treatment Strategies

Studies aim to improve patient outcomes through targeted therapeutic approaches and preventive measures.

02 Oncology Studies

Comprehensive research into various cancer types, including lymphoma, breast cancer, and lung cancer treatments. Trials evaluate novel therapeutic combinations and targeted approaches.

  • Bladder Cancer Treatments
  • Multiple Myeloma Management
  • Advanced Lung Cancer Therapy

Focus on improving survival rates and developing more effective treatment protocols.

03 Hematology Research

Advanced studies in blood disorders, particularly focusing on acute myeloid leukemia and lymphoblastic leukemia. Specialized treatments for both adult and pediatric patients.

  • Pediatric Leukemia Protocols
  • Novel Immunotherapy Approaches
  • Targeted Molecular Therapies

Emphasis on improving survival rates and developing personalized treatment strategies.

Back to IcelandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.